NCT00109044

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 540 (planned)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy and safety of a fixed-dose escitalopram combination relative to its component monotherapies and to placebo in patients with major depressive disorder.

Conditions

• Major Depressive Disorder

Interventions

Type	Name	Description
DRUG	Escitalopram

Timeline

• Start date: 2005-03-01
• Primary completion: 2006-05-01
• Completion: 2006-05-01
• First posted: 2005-04-25
• Last updated: 2012-03-05

Locations

18 sites across 1 country: United States